Letter to the editor
Diagnosing transthyretin amyloidosis in patients with known genetic cardiomyopathies – opportunities and open questions. Response
Esteban Martín-Álvarez a b José María Larrañaga-Moreira a b María Generosa Crepo-Leiro a b c Roberto Barriales-Villa a b c
a
Servicio de Cardiología, Hospital Universitario de A Coruña, A Coruña, Spain
b
Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain
c
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
For the purchase of this article it is necessary to fill in the following form:
Customer service
Phone
Calls from Spain
932 415 960
Llamadas desde el extranjero
+34 932 415 960
Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm.